Applied Health Economics and Health Policy

2008 - 2025

Current editor(s): Timothy Wrightson

From Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 15, issue 6, 2017

Decision Making and Priority Setting: The Evolving Path Towards Universal Health Coverage pp. 697-706

Francesco Paolucci, Ken Redekop, Ayman Fouda and Gianluca Fiorentini

Towards Universal Health Coverage via Social Health Insurance in China: Systemic Fragmentation, Reform Imperatives, and Policy Alternatives pp. 707-716

Alex Jingwei He and Shaolong Wu

Achieving and Sustaining Universal Health Coverage: Fiscal Reform of the National Health Insurance in Taiwan pp. 717-731

Jesse Yu-Chen Lan

Horses for Courses: Moving India towards Universal Health Coverage through Targeted Policy Design pp. 733-744

Dayashankar Maurya, Altaf Virani and S. Rajasulochana

Competitive Health Markets and Risk Equalisation in Australia: Lessons Learnt from Other Countries pp. 745-754

Ayman Fouda, Gianluca Fiorentini and Francesco Paolucci

How a Bottom-Up Multi-Stakeholder Initiative Helped Transform the Renal Replacement Therapy Landscape in Spain pp. 755-762

Rafael Selgas, Laura Rodriguez, Juan Carlos Julian, Cesar Remon, Mario Prieto-Velasco, Javier Perez-Contreras and Miguel Perez Fontan

Economic Evaluation of Interventions for Children with Neurodevelopmental Disorders: Opportunities and Challenges pp. 763-772

Ramesh Lamsal and Jennifer D. Zwicker

Health Expenditure and All-Cause Mortality in the ‘Galaxy’ of Italian Regional Healthcare Systems: A 15-Year Panel Data Analysis pp. 773-783

Davide Golinelli, Fabrizio Toscano, Andrea Bucci, Jacopo Lenzi, Maria Pia Fantini, Nicola Nante and Gabriele Messina

A Cost-Benefit Analysis of Two Alternative Models of Maternity Care in Ireland pp. 785-794

Christopher G. Fawsitt, Jane Bourke, Aileen Murphy, Brendan McElroy, Jennifer E. Lutomski, Rosemary Murphy and Richard A. Greene

Robustness and Effectiveness of the Triage System in the Pediatric Context pp. 795-803

Marcello Montefiori, Enrico di Bella, Lucia Leporatti and Paolo Petralia

Estimated Healthcare Costs of Melanoma in Australia Over 3 Years Post-Diagnosis pp. 805-816

Thomas M. Elliott, David C. Whiteman, Catherine M. Olsen and Louisa G. Gordon

Erratum to: Estimated Healthcare Costs of Melanoma in Australia Over 3 Years Post-Diagnosis pp. 817-818

Thomas M. Elliott, David C. Whiteman, Catherine M. Olsen and Louisa G. Gordon

Volume 15, issue 5, 2017

Clinical Governance in Italy: ‘Made in England’ for Import? pp. 541-544

Livio Garattini and Anna Padula

Out-of-Pocket Payments and Subjective Unmet Need of Healthcare pp. 545-555

Erik Schokkaert, Jonas Steel and Carine Van de Voorde

Is Compulsory Licensing Bad for Public Health? Some Critical Comments on Drug Accessibility in Developing Countries pp. 557-565

Samira Guennif

The XprESS Multi-Sinus Dilation System for the Treatment of Chronic Sinusitis: A NICE Medical Technology Guidance pp. 567-582

Michelle Jenks, Iain Willits, Emily Eaton Turner, Neil Hewitt, Mick Arber, Helen Cole, Joyce Craig and Andrew Sims

Economic Evaluations of Thrombophilia Screening Prior to Prescribing Combined Oral Contraceptives: A Systematic and Critical Review pp. 583-595

Erin Vernon, Bridget Hiedemann and Bonnie H. Bowie

Predicting Productivity Losses from Health-Related Quality of Life Using Patient Data pp. 597-614

Clara Mukuria, Donna Rowen, Mónica Hernández-Alava, Simon Dixon and Roberta Ara

User Fees in General Practice: Willingness to Pay and Potential Substitution Patterns—Results from a Danish GP Patient Survey pp. 615-624

Christian Kronborg, Line Bjørnskov Pedersen, Anders Fournaise and Christel Nøhr Kronborg

Role of Cost on Failure to Access Prescribed Pharmaceuticals: The Case of Statins pp. 625-634

Ian McRae, Kees Gool, Jane Hall and Laurann Yen

A Cost-Effectiveness Model for Frail Older Persons: Development and Application to a Physiotherapy-Based Intervention pp. 635-645

Jonathan Karnon, Hossein Haji Ali Afzali, Gregorius Virgianto Arpuji Anggoro Putro, Phyu Win Thant, Ameline Dompok, Ingrid Cox, Owen Henry Chikhwaza, Xian Wang, Mercy Mukui Mwangangi, Matahari Farransahat and Ian Cameron

Stated Uptake of Physical Activity Rewards Programmes Among Active and Insufficiently Active Full-Time Employees pp. 647-656

Semra Ozdemir, Marcel Bilger and Eric A. Finkelstein

Cost Effectiveness of Genotype-Guided Warfarin Dosing in Patients with Mechanical Heart Valve Replacement Under the Fee-for-Service System pp. 657-667

Dong-Jin Kim, Ho-Sook Kim, Minkyung Oh, Eun-Young Kim and Jae-Gook Shin

A Head-to-Head Comparison of UK SF-6D and Thai and UK EQ-5D-5L Value Sets in Thai Patients with Chronic Diseases pp. 669-679

Phantipa Sakthong and Wipaporn Munpan

Cost of Trauma Care in Secondary- and Tertiary-Care Public Sector Hospitals in North India pp. 681-692

Ankur Sangwan, Shankar Prinja, Sameer Aggarwal, Jagnoor Jagnoor, Pankaj Bahuguna and Rebecca Ivers

Volume 15, issue 4, 2017

We Propose a Novel Measure for Social Welfare and Public Health: Capability-Adjusted Life-Years, CALYs pp. 437-440

Anna Månsdotter, Björn Ekman, Inna Feldman, Lars Hagberg, Anna-Karin Hurtig and Lars Lindholm

Clinical, Economic and Policy Implications of Drug Shortages in the European Union pp. 441-445

Elfi De Weerdt, Steven Simoens, Minne Casteels and Isabelle Huys

Drug Pricing in South Korea pp. 447-453

Hye-Young Kwon and Brian Godman

Spectra Optia® for Automated Red Blood Cell Exchange in Patients with Sickle Cell Disease: A NICE Medical Technology Guidance pp. 455-468

Iain Willits, Helen Cole, Roseanne Jones, Kimberley Carter, Mick Arber, Michelle Jenks, Joyce Craig and Andrew Sims

A Review of NICE Methods and Processes Across Health Technology Assessment Programmes: Why the Differences and What is the Impact? pp. 469-477

Emma Cowles, Grace Marsden, Amanda Cole and Nancy Devlin

Economic Analysis and Budget Impact of Tenofovir and Entecavir in the First-Line Treatment of Hepatitis B Virus in Italy pp. 479-490

Matteo Ruggeri, M. Basile, Silvia Coretti, Carlo Drago and A. Cicchetti

Estimating Willingness to Pay for Online Health Services with Discrete-Choice Experiments pp. 491-500

Jieun Chang, Scott Savage and Donald M. Waldman

Cost‐Effectiveness Analysis of Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukaemia in Portuguese Patients who are Unsuitable for Full-Dose Fludarabine-Based Therapy pp. 501-512

Ana Teresa Paquete, Luís Silva Miguel, Ursula Becker, Catarina Pereira and Carlos Gouveia Pinto

The Medicaid Rebate: Changes in Oncology Drug Prices After the Affordable Care Act pp. 513-520

Ali Bonakdar Tehrani and Norman V. Carroll

Cost-Effectiveness of Different Population Screening Strategies for Hereditary Haemochromatosis in Australia pp. 521-534

Barbara Graaff, Amanda Neil, Lei Si, Kwang Chien Yee, Kristy Sanderson, Lyle Gurrin and Andrew J. Palmer

Comment on: “Measuring the Volume–Outcome Relation for Complex Hospital Surgery” pp. 535-536

Harold S. Luft

Authors’ Reply to Luft: “Measuring the Volume-Outcome Relation for Complex Hospital Surgery” pp. 537-538

Vivian Ho, Woohyeon Kim and Stephen Wolff

Erratum to: Spectra Optia® for Automated Red Blood Cell Exchange in Patients with Sickle Cell Disease: A NICE Medical Technology Guidance pp. 539-539

Iain Willits, Helen Cole, Roseanne Jones, Kimberley Carter, Mick Arber, Michelle Jenks, Joyce Craig and Andrew Sims

Volume 15, issue 3, 2017

Aligning Health Economics Methods to Fit with the Changing World of Public Health pp. 287-289

Emma Frew

Malaria and Economic Evaluation Methods: Challenges and Opportunities pp. 291-297

Tom L. Drake and Yoel Lubell

Geographic Resource Allocation Based on Cost Effectiveness: An Application to Malaria Policy pp. 299-306

Tom L. Drake, Yoel Lubell, Shwe Sin Kyaw, Angela Devine, Myat Phone Kyaw, Nicholas P. J. Day, Frank M. Smithuis and Lisa J. White

How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries pp. 307-321

Sabine Vogler, Valérie Paris, Alessandra Ferrario, Veronika J. Wirtz, Kees Joncheere, Peter Schneider, Hanne Bak Pedersen, Guillaume Dedet and Zaheer-Ud-Din Babar

Screen Time and Health Indicators Among Children and Youth: Current Evidence, Limitations and Future Directions pp. 323-331

Travis J. Saunders and Jeff K. Vallance

Cost-Effectiveness Models in Breast Cancer Screening in the General Population: A Systematic Review pp. 333-351

Irmgard C. Schiller-Frühwirth, Beate Jahn, Marjan Arvandi and Uwe Siebert

Does Insurance Status Influence a Patient’s Hospital Charge? pp. 353-362

Lindsey Woodworth, Patrick S. Romano and James F. Holmes

Clinical and Cost Effectiveness of Apixaban Compared to Aspirin in Patients with Atrial Fibrillation: An Australian Perspective pp. 363-374

Zanfina Ademi, Kumar Pasupathi and Danny Liew

Utility Estimates of Disease-Specific Health States in Prostate Cancer from Three Different Perspectives pp. 375-384

Katharine S. Gries, Dean A. Regier, Scott D. Ramsey and Donald L. Patrick

Can a Circular Payment Card Format Effectively Elicit Preferences? Evidence From a Survey on a Mandatory Health Insurance Scheme in Tunisia pp. 385-398

Olivier Chanel, Khaled Makhloufi and Mohammad Abu-Zaineh

An Empirical Comparison of the EQ-5D-5L, DEMQOL-U and DEMQOL-Proxy-U in a Post-Hospitalisation Population of Frail Older People Living in Residential Aged Care pp. 399-412

Julie Ratcliffe, Thomas Flint, Tiffany Easton, Maggie Killington, Ian Cameron, Owen Davies, Craig Whitehead, Susan Kurrle, Michelle Miller, Enwu Liu and Maria Crotty

Economic Evaluation of Community-Based Case Management of Patients Suffering From Chronic Obstructive Pulmonary Disease pp. 413-424

Sabrina Storgaard Sørensen, Kjeld Møller Pedersen, Ulla Møller Weinreich and Lars Ehlers

Assessing Equity in the Provision of Primary Healthcare Centers in Buenos Aires Province (Argentina): A Stochastic Frontier Analysis pp. 425-433

Florencia Arnaudo, Fernando Lago and Valentina Viego

Erratum to: Malaria and Economic Evaluation Methods: Challenges and Opportunities pp. 435-435

Tom L. Drake and Yoel Lubell

Volume 15, issue 2, 2017

Ethical Hurdles in the Prioritization of Oncology Care pp. 119-126

Folkert Groot, Stefano Capri, Jean-Claude Castanier, David Cunningham, Bruno Flamion, Mathias Flume, Harald Herholz, Lars-Åke Levin, Oriol Solà-Morales, Christoph J. Rupprecht, Natalie Shalet, Andrew Walker and Olivier Wong

EQ-5D and the EuroQol Group: Past, Present and Future pp. 127-137

Nancy Devlin and Richard Brooks

Virtual Touch™ Quantification to Diagnose and Monitor Liver Fibrosis in Hepatitis B and Hepatitis C: A NICE Medical Technology Guidance pp. 139-154

Jennifer A. Summers, Muralikrishnan Radhakrishnan, Elizabeth Morris, Anastasia Chalkidou, Tiago Rua, Anita Patel, Viktoria McMillan, Abdel Douiri, Yanzhong Wang, Salma Ayis, Joanne Higgins, Stephen Keevil, Cornelius Lewis and Janet Peacock

Amplifying Each Patient’s Voice: A Systematic Review of Multi-criteria Decision Analyses Involving Patients pp. 155-162

Kevin Marsh, J. Jaime Caro, Alaa Hamed and Erica Zaiser

Many Miles to Go: A Systematic Review of the State of Cost-Utility Analyses in Brazil pp. 163-172

Alessandro G. Campolina, Luciana M. Rozman, Tassia C. Decimoni, Roseli Leandro, Hillegonda M. D. Novaes and Patrícia Coelho De Soárez

Cost-Effectiveness of Non-Invasive and Non-Pharmacological Interventions for Low Back Pain: a Systematic Literature Review pp. 173-201

Lazaros Andronis, Philip Kinghorn, Suyin Qiao, David G. T. Whitehurst, Susie Durrell and Hugh McLeod

Financial Impact of Direct-Acting Oral Anticoagulants in Medicaid: Budgetary Assessment Based on Number Needed to Treat pp. 203-214

Kathleen A. Fairman, Lindsay E. Davis, Courtney R. Kruse and David A. Sclar

Determinants of Voluntary National Health Insurance Drop-Out in Eastern Sudan pp. 215-226

Chantal Herberholz and Wael Ahmed Fakihammed

Estimating Population Health Benefits Associated with Specialty and Traditional Drugs in the Year Following Product Approval pp. 227-235

James D. Chambers, Teja Thorat, Colby L. Wilkinson, Mark Salem, Prasun Subedi, Sachin J. Kamal-Bahl and Peter J. Neumann

Cost Effectiveness of Insulin Degludec Plus Liraglutide (IDegLira) in a Fixed Combination for Uncontrolled Type 2 Diabetes Mellitus in Sweden pp. 237-248

Åsa Ericsson and Adam Lundqvist

Sustaining Gains in Health Programs: Technical Efficiency and its Determinants in Malaria Programs in Sub-Saharan Africa pp. 249-259

Esso-Hanam Atake

Assessment of Public Health and Economic Impact of Intranasal Live-Attenuated Influenza Vaccination of Children in France Using a Dynamic Transmission Model pp. 261-276

L. Gerlier, M. Lamotte, S. Grenèche, X. Lenne, F. Carrat, C. Weil-Olivier, O. Damm, M. Schwehm and M. Eichner

Budget Impact Analysis of Biosimilar Trastuzumab for the Treatment of Breast Cancer in Croatia pp. 277-286

August Cesarec and Robert Likić

Volume 15, issue 1, 2017

‘Appropriateness’ in Italy: A ‘Magic Word’ in Pharmaceuticals? pp. 1-3

Livio Garattini and Anna Padula

The Use of Surrogate and Patient-Relevant Endpoints in Outcomes-Based Market Access Agreements pp. 5-11

Mondher Toumi, Szymon Jarosławski, Toyohiro Sawada and Åsa Kornfeld

Economic Crisis, Austerity Policies, Health and Fairness: Lessons Learned in Spain pp. 13-21

Beatriz G. Lopez-Valcarcel and Patricia Barber

Health State Utility Values for Age-Related Macular Degeneration: Review and Advice pp. 23-32

Thomas Butt, Adnan Tufail and Gary Rubin

Economic Evaluation in Ethiopian Healthcare Sector Decision Making: Perception, Practice and Barriers pp. 33-43

Elias Asfaw Zegeye, Josue Mbonigaba, Sylvia Blanche Kaye and Thomas Wilkinson

Panobinostat Plus Bortezomib Versus Lenalidomide in Patients with Relapsed and/or Refractory Multiple Myeloma: A Matching-Adjusted Indirect Treatment Comparison of Survival Outcomes using Patient-level Data pp. 45-55

Istvan Majer, Gijs Wetering, Zoltan Polanyi, Arun Krishna, Elisabeth Gray and Anuja Roy

Delivery of Essential Medicines to Primary Care Institutions and its Association with Procurement Volume and Price: A Case Study in Hubei Province, China pp. 57-64

Yuqing Tang, Chaojie Liu and Xinping Zhang

Assessing the Effect of Potential Reductions in Non-Hepatic Mortality on the Estimated Cost-Effectiveness of Hepatitis C Treatment in Early Stages of Liver Disease pp. 65-74

Andrew J. Leidner, Harrell W. Chesson, Philip R. Spradling and Scott D. Holmberg

The Cost-Effectiveness of Oral Nutrition Supplementation for Malnourished Older Hospital Patients pp. 75-83

Yue Zhong, Joshua T. Cohen, Scott Goates, Menghua Luo, Jeffrey Nelson and Peter J. Neumann

Inflammatory Bowel Diseases (Crohn´s Disease and Ulcerative Colitis): Cost of Treatment in Serbia and the Implications pp. 85-93

Marina Kostić, Ljiljan Djakovic, Raša Šujić, Brian Godman and Slobodan M. Janković

A Cost-Utility Analysis of Prostate Cancer Screening in Australia pp. 95-111

Andrew Keller, Christian Gericke, Jennifer A. Whitty, John Yaxley, Boon Kua, Geoff Coughlin and Troy Gianduzzo

Promoting Antibacterial Drug Development: Select Policies and Challenges pp. 113-118

Aylin Sertkaya, Amber Jessup and Hui-Hsing Wong